Prelude Therapeutics Inc
PRLD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001678660
No open-market purchases or sales by Prelude Therapeutics Inc insiders were filed in the last 90 days; 75 institutions reported holding it in 13F filings for Q2 2026, worth $264.3M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Prelude Therapeutics Inc changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 47 | 48 | +1 |
| Shares | 27.2M | 28.5M | +1.31M (+4.8%) |
| Value | $39.1M | $82.6M | +$43.5M (+111.1%) |
New holders (10)
Institutions that held Prelude Therapeutics Inc at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Kynam Capital Management, LP | 788,867 | $2.29M | 0.15% |
| Marshall Wace, LLP | 273,883 | $794.3K | 0.00% |
| Susquehanna International Group, LLP | 135,909 | $394.1K | 0.00% |
| Sphera Funds Management Ltd. | 122,752 | $356.0K | 0.07% |
| Omers Administration Corp | 73,000 | $211.7K | 0.00% |
| Point72 Asset Management, L.P. | 59,168 | $171.6K | 0.00% |
| Colony Group, LLC | 50,007 | $145.0K | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 46,090 | $133.7K | 0.00% |
| Qube Research & Technologies Ltd | 21,551 | $62.5K | 0.00% |
| Caldwell Sutter Capital, Inc. | 2,000 | $5.80K | 0.00% |
Sold out (9)
Institutions that held Prelude Therapeutics Inc at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Shay Capital LLC | 100,000 | $144.0K |
| Gsa Capital Partners LLP | 75,161 | $108.0K |
| HRT Financial LP | 16,901 | $24.0K |
| AQR Capital Management LLC | 10,500 | $15.1K |
| Tower Research Capital LLC (TRC) | 6,927 | $9.97K |
| EverSource Wealth Advisors, LLC | 89 | $128 |
| Essential Partners LLC | 17 | $24 |
| SRS Capital Advisors, Inc. | 15 | $22 |
| Simplex Trading, LLC | 153 | $0 |